Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-15

Clinical Trial Update: The Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension on Outpatients With Gastroesophageal Reflux Disease [NA]

View source ↗

Summary

This update reports the completion of a clinical trial evaluating the anti-gastroesophageal reflux effects of Anvitra Gastric Suspension in outpatients with gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anvitra Gastric Suspension

Snippet

Sponsor: Haiphong University of Medicine and Pharmacy | Conditions: GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency, GERD (Heartburn, Regurgitation, and Dyspepsia) Severity | NA | Status: COMPLETED